Thrombocytopenia and intra-cerebral complications associated with low-molecular-weight heparin treatment in patients undergoing total hip replacement. A report of two cases.
Lilikakis
Anastasios K
AK
Orthopaedic Department, NIMTS Hospital, Athens, Greece. alilikakis@yahoo.com
Papapolychroniou
Theodoros
T
Macheras
Georgios
G
Michelinakis
Emmanuel
E
D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D013921:Thrombocytopenia / Q000139:chemically induced*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight